Bordetella pertussis Overview
30 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which virulence factor of Bordetella pertussis disables Gi proteins?

  • Adenylate cyclase toxin
  • Lymphocytosis factor
  • Pertussis toxin (correct)
  • Tracheal cytotoxin

    • What is a common presentation in Brucella infections?

  • Undulant fever (correct)
  • High-grade fever
  • Pneumonia
  • Severe abdominal pain

    • What is the first clinical stage of Bordetella pertussis infection?

  • Convalescent
  • Catarrhal (correct)
  • Paroxysmal
  • Acute

    • Which treatment is recommended for a confirmed Bordetella pertussis infection in a patient not allergic to first-line antibiotics?

    <p>Macrolides</p> Signup and view all the answers

    How is Brucella primarily transmitted to humans?

    <p>Ingestion of contaminated animal products</p> Signup and view all the answers

    Which clinical stage of Bordetella pertussis is characterized by intense coughing followed by a whoop?

    <p>Paroxysmal</p> Signup and view all the answers

    What unique laboratory finding is produced by Bordetella pertussis infections?

    <p>Lymphocytosis</p> Signup and view all the answers

    What is the primary treatment regimen for a Brucella infection in adults?

    <p>Doxycycline and rifampin</p> Signup and view all the answers

    How does Bordetella pertussis primarily exert its effect on host cells?

    <p>Disabling Gi proteins</p> Signup and view all the answers

    What common symptom is associated with Brucella infections?

    <p>Undulant fever</p> Signup and view all the answers

    What is a notable characteristic of Bordetella pertussis infections compared to most acute bacterial infections?

    <p>Results in lymphocytosis</p> Signup and view all the answers

    Which clinical presentations are typically associated with Brucella infections?

    <p>Undulant fever and night sweats</p> Signup and view all the answers

    What is the primary purpose of Tdap and DTaP vaccines in relation to Bordetella pertussis?

    <p>To reduce the incidence of whooping cough</p> Signup and view all the answers

    Which treatment regimen is recommended for someone with a confirmed Brucella infection?

    <p>Doxycycline and rifampin or streptomycin</p> Signup and view all the answers

    How does Bordetella pertussis affect the cellular processes in human hosts?

    <p>It disables Gi proteins</p> Signup and view all the answers

    Which of the following virulence factors is characteristic of Bordetella pertussis?

    <p>Adenylate cyclase toxin</p> Signup and view all the answers

    What is the primary clinical presentation of Brucella infections?

    <p>Undulant fever</p> Signup and view all the answers

    What distinguishes the paroxysmal stage of Bordetella pertussis infection?

    <p>Intense coughing followed by a whoop</p> Signup and view all the answers

    How does Brucella survive after transmission to humans?

    <p>By surviving in macrophages</p> Signup and view all the answers

    What vaccine is primarily administered for the prevention of Bordetella pertussis infections?

    <p>Tdap vaccine</p> Signup and view all the answers

    Which of the following symptoms is characteristic of the convalescent stage of Bordetella pertussis infection?

    <p>Gradual recovery of chronic cough</p> Signup and view all the answers

    What key symptom separates Brucella infections from most other acute bacterial infections?

    <p>Undulant fever</p> Signup and view all the answers

    Which treatment options are recommended for a Brucella infection?

    <p>Doxycycline + rifampin or streptomycin</p> Signup and view all the answers

    What is a notable characteristic of Bordetella pertussis when compared to other acute bacterial infections?

    <p>Produces lymphocytosis</p> Signup and view all the answers

    What is the primary virulence factor of Bordetella pertussis that increases cAMP levels in host cells?

    <p>Adenylate cyclase toxin</p> Signup and view all the answers

    What is a significant clinical feature of the paroxysmal stage of Bordetella pertussis infection?

    <p>Post-tussive vomiting</p> Signup and view all the answers

    Which treatment regimen is appropriate for a patient with Brucella infection?

    <p>Doxycycline + rifampin or streptomycin</p> Signup and view all the answers

    What is a notable characteristic that differentiates Bordetella pertussis infections from most acute bacterial infections?

    <p>Producing lymphocytosis</p> Signup and view all the answers

    Which of the following describes the mode of transmission for Brucella?

    <p>Ingestion of contaminated animal products</p> Signup and view all the answers

    What is the primary preventive measure against Bordetella pertussis infections?

    <p>Tdap and DTaP vaccines</p> Signup and view all the answers

    Study Notes

    Bordetella pertussis

    • Gram-negative, aerobic coccobacillus responsible for whooping cough.
    • Virulence Factors:
      • Pertussis toxin: Inhibits Gi protein, disrupting signaling pathways.
      • Adenylate cyclase toxin: Elevates cyclic AMP (cAMP) levels, impacting immune response.
      • Tracheal cytotoxin: Damages respiratory epithelial cells.
    • Clinical Stages:
      • Catarrhal Stage: Characterized by low-grade fever and coryza (inflammation of the nasal mucosa).
      • Paroxysmal Stage: Features intense coughing fits followed by a "whoop" sound during inhalation; may lead to post-tussive vomiting.
      • Convalescent Stage: Gradual recovery with a chronic cough persisting.
    • Prevention: Vaccination with Tdap for adults and DTaP for children helps prevent infection.
    • Produces lymphocytosis, distinguishing it from most acute bacterial infections.
    • Treatment:
      • Macrolides are the first-line treatment.
      • If allergic to macrolides, trimethoprim-sulfamethoxazole (TMP-SMX) can be used.

    Brucella

    • Gram-negative, aerobic coccobacillus known for causing brucellosis.
    • Transmission:
      • Spread primarily through ingestion of contaminated animal products, particularly unpasteurized milk.
      • Survivors within macrophages in the reticuloendothelial system, leading to persistent infection.
    • Forms noncaseating granulomas, which can be a hallmark of the infection.
    • Presentation:
      • Characterized by undulant fever (fluctuating fever patterns).
      • Accompanied by night sweats and arthralgia (joint pain).
    • Treatment:
      • Recommended regimen includes doxycycline in combination with rifampin or streptomycin for effective management.

    Bordetella pertussis

    • Gram-negative, aerobic coccobacillus responsible for whooping cough.
    • Virulence Factors:
      • Pertussis toxin: Inhibits Gi protein, disrupting signaling pathways.
      • Adenylate cyclase toxin: Elevates cyclic AMP (cAMP) levels, impacting immune response.
      • Tracheal cytotoxin: Damages respiratory epithelial cells.
    • Clinical Stages:
      • Catarrhal Stage: Characterized by low-grade fever and coryza (inflammation of the nasal mucosa).
      • Paroxysmal Stage: Features intense coughing fits followed by a "whoop" sound during inhalation; may lead to post-tussive vomiting.
      • Convalescent Stage: Gradual recovery with a chronic cough persisting.
    • Prevention: Vaccination with Tdap for adults and DTaP for children helps prevent infection.
    • Produces lymphocytosis, distinguishing it from most acute bacterial infections.
    • Treatment:
      • Macrolides are the first-line treatment.
      • If allergic to macrolides, trimethoprim-sulfamethoxazole (TMP-SMX) can be used.

    Brucella

    • Gram-negative, aerobic coccobacillus known for causing brucellosis.
    • Transmission:
      • Spread primarily through ingestion of contaminated animal products, particularly unpasteurized milk.
      • Survivors within macrophages in the reticuloendothelial system, leading to persistent infection.
    • Forms noncaseating granulomas, which can be a hallmark of the infection.
    • Presentation:
      • Characterized by undulant fever (fluctuating fever patterns).
      • Accompanied by night sweats and arthralgia (joint pain).
    • Treatment:
      • Recommended regimen includes doxycycline in combination with rifampin or streptomycin for effective management.

    Bordetella pertussis

    • Gram-negative, aerobic coccobacillus responsible for whooping cough.
    • Virulence Factors:
      • Pertussis toxin: Inhibits Gi protein, disrupting signaling pathways.
      • Adenylate cyclase toxin: Elevates cyclic AMP (cAMP) levels, impacting immune response.
      • Tracheal cytotoxin: Damages respiratory epithelial cells.
    • Clinical Stages:
      • Catarrhal Stage: Characterized by low-grade fever and coryza (inflammation of the nasal mucosa).
      • Paroxysmal Stage: Features intense coughing fits followed by a "whoop" sound during inhalation; may lead to post-tussive vomiting.
      • Convalescent Stage: Gradual recovery with a chronic cough persisting.
    • Prevention: Vaccination with Tdap for adults and DTaP for children helps prevent infection.
    • Produces lymphocytosis, distinguishing it from most acute bacterial infections.
    • Treatment:
      • Macrolides are the first-line treatment.
      • If allergic to macrolides, trimethoprim-sulfamethoxazole (TMP-SMX) can be used.

    Brucella

    • Gram-negative, aerobic coccobacillus known for causing brucellosis.
    • Transmission:
      • Spread primarily through ingestion of contaminated animal products, particularly unpasteurized milk.
      • Survivors within macrophages in the reticuloendothelial system, leading to persistent infection.
    • Forms noncaseating granulomas, which can be a hallmark of the infection.
    • Presentation:
      • Characterized by undulant fever (fluctuating fever patterns).
      • Accompanied by night sweats and arthralgia (joint pain).
    • Treatment:
      • Recommended regimen includes doxycycline in combination with rifampin or streptomycin for effective management.

    Bordetella pertussis

    • Gram-negative, aerobic coccobacillus responsible for whooping cough.
    • Virulence Factors:
      • Pertussis toxin: Inhibits Gi protein, disrupting signaling pathways.
      • Adenylate cyclase toxin: Elevates cyclic AMP (cAMP) levels, impacting immune response.
      • Tracheal cytotoxin: Damages respiratory epithelial cells.
    • Clinical Stages:
      • Catarrhal Stage: Characterized by low-grade fever and coryza (inflammation of the nasal mucosa).
      • Paroxysmal Stage: Features intense coughing fits followed by a "whoop" sound during inhalation; may lead to post-tussive vomiting.
      • Convalescent Stage: Gradual recovery with a chronic cough persisting.
    • Prevention: Vaccination with Tdap for adults and DTaP for children helps prevent infection.
    • Produces lymphocytosis, distinguishing it from most acute bacterial infections.
    • Treatment:
      • Macrolides are the first-line treatment.
      • If allergic to macrolides, trimethoprim-sulfamethoxazole (TMP-SMX) can be used.

    Brucella

    • Gram-negative, aerobic coccobacillus known for causing brucellosis.
    • Transmission:
      • Spread primarily through ingestion of contaminated animal products, particularly unpasteurized milk.
      • Survivors within macrophages in the reticuloendothelial system, leading to persistent infection.
    • Forms noncaseating granulomas, which can be a hallmark of the infection.
    • Presentation:
      • Characterized by undulant fever (fluctuating fever patterns).
      • Accompanied by night sweats and arthralgia (joint pain).
    • Treatment:
      • Recommended regimen includes doxycycline in combination with rifampin or streptomycin for effective management.

    Bordetella pertussis

    • Gram-negative, aerobic coccobacillus responsible for whooping cough.
    • Virulence Factors:
      • Pertussis toxin: Inhibits Gi protein, disrupting signaling pathways.
      • Adenylate cyclase toxin: Elevates cyclic AMP (cAMP) levels, impacting immune response.
      • Tracheal cytotoxin: Damages respiratory epithelial cells.
    • Clinical Stages:
      • Catarrhal Stage: Characterized by low-grade fever and coryza (inflammation of the nasal mucosa).
      • Paroxysmal Stage: Features intense coughing fits followed by a "whoop" sound during inhalation; may lead to post-tussive vomiting.
      • Convalescent Stage: Gradual recovery with a chronic cough persisting.
    • Prevention: Vaccination with Tdap for adults and DTaP for children helps prevent infection.
    • Produces lymphocytosis, distinguishing it from most acute bacterial infections.
    • Treatment:
      • Macrolides are the first-line treatment.
      • If allergic to macrolides, trimethoprim-sulfamethoxazole (TMP-SMX) can be used.

    Brucella

    • Gram-negative, aerobic coccobacillus known for causing brucellosis.
    • Transmission:
      • Spread primarily through ingestion of contaminated animal products, particularly unpasteurized milk.
      • Survivors within macrophages in the reticuloendothelial system, leading to persistent infection.
    • Forms noncaseating granulomas, which can be a hallmark of the infection.
    • Presentation:
      • Characterized by undulant fever (fluctuating fever patterns).
      • Accompanied by night sweats and arthralgia (joint pain).
    • Treatment:
      • Recommended regimen includes doxycycline in combination with rifampin or streptomycin for effective management.

    Bordetella pertussis

    • Gram-negative, aerobic coccobacillus responsible for whooping cough.
    • Virulence Factors:
      • Pertussis toxin: Inhibits Gi protein, disrupting signaling pathways.
      • Adenylate cyclase toxin: Elevates cyclic AMP (cAMP) levels, impacting immune response.
      • Tracheal cytotoxin: Damages respiratory epithelial cells.
    • Clinical Stages:
      • Catarrhal Stage: Characterized by low-grade fever and coryza (inflammation of the nasal mucosa).
      • Paroxysmal Stage: Features intense coughing fits followed by a "whoop" sound during inhalation; may lead to post-tussive vomiting.
      • Convalescent Stage: Gradual recovery with a chronic cough persisting.
    • Prevention: Vaccination with Tdap for adults and DTaP for children helps prevent infection.
    • Produces lymphocytosis, distinguishing it from most acute bacterial infections.
    • Treatment:
      • Macrolides are the first-line treatment.
      • If allergic to macrolides, trimethoprim-sulfamethoxazole (TMP-SMX) can be used.

    Brucella

    • Gram-negative, aerobic coccobacillus known for causing brucellosis.
    • Transmission:
      • Spread primarily through ingestion of contaminated animal products, particularly unpasteurized milk.
      • Survivors within macrophages in the reticuloendothelial system, leading to persistent infection.
    • Forms noncaseating granulomas, which can be a hallmark of the infection.
    • Presentation:
      • Characterized by undulant fever (fluctuating fever patterns).
      • Accompanied by night sweats and arthralgia (joint pain).
    • Treatment:
      • Recommended regimen includes doxycycline in combination with rifampin or streptomycin for effective management.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers Bordetella pertussis, the Gram-negative bacterium responsible for whooping cough. It delves into its virulence factors, clinical stages, prevention methods, and treatment options. Test your knowledge on this significant pathogen and its implications in health care.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser